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Abstract 
 
 
Objective:  With increasing prevalence of obesity, there is increased attention on 
prepregnancy BMI and its relation to pregnancy outcomes. Quantifying the 
relationship between Body Mass Index (BMI) and preeclampsia may provide rationale 
for a preconception target for intervention that may affect the incidence of 
preeclampsia. A review of the literature was performed to explore the relationship 
between prepregnancy BMI and the risk of preeclampsia. 
Methods: PubMed, Embase and Google Scholar were searched for epidemiologic 
studies (with BMI as a main exposure and preeclampsia as one of the main 
outcomes) in English published between 2000 and 2013. For each study a summary 
of study characteristics, main findings and methodology were reviewed and 
summarized. 
Results: BMI is consistently shown to be significantly associated with increased risk 
for preeclampsia, with ORs ranging from 1.7 to 7. This association appears 
independent of race/ethnicity, and the association is stronger as the BMI class 
increases from overweight to superobese. 
Conclusions: Prepregnancy BMI is associated with increased odds of preeclampsia. 
Public health interventions that focus on preconception normalization of BMI in 
women of reproductive age may impact the incidence of preeclampsia and its 
associated morbidity. 
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Background  
Preeclampsia is defined as the new onset of hypertension in pregnancy, with 
systolic blood pressure > 140 and diastolic blood pressure > 90, starting after 20 
weeks of gestation and associated with proteinuria.(1) Each year, an estimated 76,000 
maternal and 500,000 child deaths worldwide are attributed to preeclampsia.(2) 
Preeclampsia occurs in 5-8% of deliveries, affecting one in every 12 women in the 
US. Globally preeclampsia is one of the main causes of maternal mortality and 
morbidity accounting for 10-15% of maternal deaths. It is responsible for 18% of all 
maternal deaths in the US alone and 15% of premature births in developed countries. 
As the only cure for this condition is delivery, it is one of the main causes of 
premature delivery and low birth weight.(3) 
The exact cause of preeclampsia is not yet known. Abnormal placentation, 
reduced placental perfusion and inflammation are assumed to be the main 
mechanisms leading to development of preeclampsia.(57)(58) Main risk factors known 
to be associated with preeclampsia are first pregnancy, obesity (BMI>30), age (under 
18 and over 40), history of high blood pressure, diet, family history of preeclampsia, 
diabetes and paternity.(2) 
Due to tremendous financial consequences of managing this disease and its 
adverse health outcomes for the mother and newborn, preeclampsia is a research 
priority for health care. While the etiology of preeclampsia remains unclear, known 
risk factors include previous history of preeclampsia, multiple gestation, chronic 
hypertension, diabetes, first pregnancy, obesity (BMI 30 or greater), maternal age 
(over 40 or under 18), autoimmune disorders such as lupus and rheumatoid arthritis, 
in vitro fertilization, and sickle cell anemia.(4) 
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Overweight or obese body mass index has been suggested as an independent 
risk factor for preeclampsia. BMI (calculated as weight {kg} per height squared {m2}) 
is an international standard measurement for obesity and is used as a surrogate 
marker for the status of health and nutrition.(5) Between 1999 and 2003, the 
proportion of women in the US who delivered a pregnancy who had an overweight or 
obese BMI at the onset of pregnancy has increased from 37.1 to 40.5%. Given the 
increased prevalence of obesity and its association with adverse pregnancy 
outcomes such as preeclampsia, the obesity epidemic can have significant public 
health implications. 
Obesity and risk of preeclampsia 
Obesity is associated with significant metabolic and physiologic alterations. 
Adipose tissue is not simply storage of fat, but rather is a hormonally active tissue 
producing endocrine mediators such as cytokines and adipokines.(6) These mediators 
have been associated with a proinflammatory and prothrombotic state, insulin 
resistance and oxidative stress, all of which have been associated with pathogenesis 
of preeclampsia, as well as lifetime risk of maternal cardiovascular disease.(7)(8) 
Obesity is associated with increased levels of triglycerides, free fatty acids and 
reduced levels of HDL (High Density Lipoproteins) and increased or stable LDL (Low 
Density Lipoproteins).(9) The result of a lower HDL to LDL ratio and 
hypertriglyceridemia promotes an atherogenic state. Adipose tissue produces 
proinflammatory mediators such as IL-6 (Interleukin-6), TNF-alpha (Tumor Necrosis 
Factor Alpha), and CRP (C-Reactive Protein), all noted to be elevated in obese 
women compared to lean women.(10) CRP is found to be higher in pregnant women 
who develop preeclampsia (11) and one third of total effect of BMI on risk of 
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preeclampsia is found to be mediated through triglyceride level and inflammation 
including levels of CRP.(12) TNF-alpha is produced by adipose tissue, and increases 
insulin resistance, activates endothelial cells, and is associated with oxidative stress. 
TNF-alpha has been associated with both preeclampsia and obesity.(13)(14) IL-6 is 
disproportionately elevated in obese and preeclamptic individuals. As IL-6 produced 
in adipose tissue is responsible for 30% of the overall IL-6 in blood, it is assumed that 
this chemokine is associated with preeclampsia, insulin resistance and 
cardiovascular diseases later in life.(15) This chemical is assumed to play a role in 
vessel wall functioning and produces a prothrombotic state, both inducing vascular 
damage.(16) 
Increased levels of free fatty acids and inflammation cause a condition known 
as oxidative stress, where the body is not capable of eliminating harmful oxygen 
radicals. Decreased levels of antioxidants in obese individuals, has been explained 
by decreased dietary intake of antioxidants or consumption of it by high levels of 
reactive oxygen species.(17) The abundance of oxygen free radicals has been 
associated with further endothelial injury.  
Obesity has been suggested as an independent risk factor for development of 
preeclampsia. The mechanism of how obesity might cause preeclampsia is 
multifactorial. It is assumed that increase in lipids, cholesterol and triglyceride levels 
decreases the body’s capacity to fight toxicity well enough and increases oxidative 
stress, which leads to endothelial dysfunction. In addition, increased cardiac output 
and vasodilation in obese women might also cause endothelial dysfunction.(18) 
Life style factors such as diet and physical activity have been associated with 
obesity and risk of cardiovascular diseases, however the association of these factors 
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with preeclampsia remains poorly elucidated. Poor nutrition can contribute to 
cardiovascular diseases and obesity. Diets rich in antioxidants, fruits, vegetables, 
vitamins, fiber and whole grains are known to reduce the risk of cardiovascular 
disease.(19) There have been fewer studies about the role of diet in pathogenesis of 
preeclampsia and how obesity explains that.(20) In some studies deficiencies of 
certain micronutrients have been found to be negatively associated with BMI and 
other measures of body fat.(21)(22) It is suggested that dietary excess such as 
increased intake of refined food, as well as some dietary deficiencies explain the 
association between obesity and preeclampsia.   
Physical activity is known to reduce the risk of obesity and cardiovascular 
diseases. In addition, data from observational studies show that exercise may reduce 
the risk of preeclampsia. Studies have shown association between physical activity 
(leisure time and occupational activities) during and before pregnancy to be 
associated with reduced risk of preeclampsia..(23)(24)(25) Data from these studies show 
that physical activity including recreational activities one year before pregnancy and 
in early pregnancy is associated with reduced risk of preeclampsia. According to 
these studies, reduced physical activity may explain the association between obesity 
and risk of preeclampsia as well as cardiovascular diseases risk.  
As preeclampsia is associated with significant morbidity and the literature 
suggests commonalities in the pathogenesis of adverse effects of obesity and 
preeclampsia, prepregnancy BMI may be a target for pubic health focus to reduce the 
risk of preeclampsia. The goal of this review is to explore how strongly high BMI is 
associated with preeclampsia and thus quantify the association of BMI and 
preeclampsia. This literature review can be used to direct future interventions 
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targeting preconception health and further studies into the etiology of preeclampsia in 
relation to prepregnancy BMI. 
Methods 
PubMed, Embase and Google Scholar were searched during the month of 
January 2013 using the following search terms: (“body mass index” or “obesity” or 
“overweight” or “adiposity”) and (“preeclampsia” or “pregnancy induced hypertension” 
or “eclampsia” or “gestational hypertension”).  References from published articles and 
systematic reviews were also reviewed for recent studies. Criteria for inclusion 
included English language epidemiologic studies (case series, cohort or 
interventional trials) published between 2000- 2013, preeclampsia or gestational 
hypertension as one of its outcomes, and, BMI as the primary exposure studied. 
Studies were included where, overweight, obese and severely obese were defined as 
follows: overweight (BMI 25-30), obese (BMI 30-35) and severely obese BMI (>35). 
Preeclampsia was defined as gestational hypertension and proteinuria. Gestational 
hypertension defined as two or more measurements of systolic blood pressure 
persistently ≥ 140mmHg and/or diastolic blood pressure persistently ≥ 90mmHg for 
the first time after 20 weeks of gestation. Proteinuria was defined as the excretion of 
> 300mg of protein in 24 hours, a random sample of 2+, a catheterized sample of 1+ 
or a protein-creatinine ratio > 0.3.  
Studies were excluded if they were in languages other than English, were 
published before 2000 or had fewer than 200 participants studied.   
Abstracts were reviewed for potential inclusion and if appropriate, the article 
was reviewed. Data from the literature review were abstracted on a structured case 
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report form. The results were reported as OR and adjusted OR for the association of 
overweight or obese BMI and preeclampsia.
Results 
A total of 50 articles were identified for this study. Of this only 10 met the inclusion criteria. Table (1) gives an 
overview of each study characteristics. Table (2) summarizes ORs for three BMI categories in each study:   
Table (1) Characteristics of studies examining the relationship between prepregnancy Body Mass Index and 
preeclampsia 
# Study Country Type of study 
Study size 
Study Size Maternal 
inclusion criteria 
Maternal 
exclusion criteria 
1 Effect of prepregnancy 
maternal overweight and 
obesity on pregnancy 
outcome.  
Ovesen et al. 2011(26) 
 
Denmark Prospective 
cohort 
 
369,347  
 
Singleton 
pregnancy 
Incorrect or missing 
data on BMI,  
2 Associations of maternal 
obesity with blood 
pressure and the risks of 
gestational hypertensive 
disorders. The 
generation R study 
Gaillard et al. 2011(27) 
 
Netherlands Prospective 
cohort  
 
6902  
 
Low risk 
pregnancy 
No data on BMI 
and blood pressure, 
history of 
hypertension, fetal 
deaths, induced 
abortion and twin 
pregnancies,  
3 Determinants of 
preeclampsia: a case 
control study in a district 
hospital in south India. 
Kumar  et al. 2010(28) 
 
 
India Case control 
study  
100 cases 
100 controls 
Diagnosed with 
preeclampsia 
 
No information 
provided 
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4 Prepregnancy body 
mass index, gestational 
weight gain, and risk of 
hypertensive pregnancy 
among Latina women. 
Fortner R.T et al., 
2009(29) 
US Prospective 
cohort  
 
1043  
 
Latina women 
prior to 24 weeks 
gestation.  
Multiple gestation, 
Diabetes Mellitus, 
hypertension, heart 
disease, chronic 
renal disease, 
medications 
affecting glucose 
tolerance, <16 or 
>40,  
 
5 Prepregnancy weight 
status and the risk of 
adverse pregnancy 
outcomes. Haugher M.S 
et al., 2008(30) 
 
Argentina Prospective 
cohort  
46,964 Pregnancy Congenital 
malformations, 
multiplets,  
6 Prepregnancy body 
mass index and adverse 
pregnancy outcomes. 
Driul L et all, 2008(31) 
Italy Prospective 
cohort  
916  Singleton 
pregnancy, 
Twins, chronic 
hypertension, 
history of preterm 
delivery 
before 37 weeks, 
history of neonatal 
death, diabetes and 
gestational 
diabetes in the 
current or previous 
pregnancies, 
elective Caesarean 
section. 
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7 Prepregnancy body 
mass index and the 
occurrence of severe 
hypertensive disorders 
of pregnancy. Bodnar 
L.M et al., 2007(32) 
 
US Prospective 
cohort  
 
38188 Singleton 
pregnancy 
Chronic 
hypertension or 
elevated blood 
pressure before 24 
weeks’ gestation 
8 Effect of prepregnancy 
body mass index 
categories on obstetrical 
and neonatal outcomes. 
Haim A et al., 2007(33) 
 
Canada Retrospective 
cohort  
18,643 Pregnancy No information 
9 The risk of preeclampsia 
rises with increasing 
prepregnancy body 
mass index. Bodnar L.M 
et al.. 2005 (34) 
US Prospective 
cohort of  
1179 Primiparous 
pregnancy less 
than 16 weeks 
gestation 
Chronic 
hypertension, 
diabetes mellitus, 
or HIV infection, or 
a positive 
toxicology screen 
spontaneous or 
therapeutic 
abortion 
 
10 Adult weight change, 
weight cycling, and 
prepregnancy obesity in 
relation to risk of 
preeclampsia. Frederick 
I.O et al. 2006(35) 
US Prospective 
cohort of  
1644 women Multiparous and 
nulliparous 
pregnancy 
Abortion or fetal 
demise before 28 
weeks of gestation 
pregestational 
diabetes  
chronic or essential 
hypertension 
 
Table (2) Odds Ratios and Confidence Intervals reported for three BMI 
categories 
Study Overweight 
BMI (25-30) 
Odds Ratio 
95% CI 
Obese 
BMI (30-35) 
Odds Ratio 
95% CI 
Severely obese 
BMI (>35) 
Odds Ratio 
95% CI 
Effect of prepregnancy 
maternal overweight 
and obesity on 
pregnancy outcome. 
 
1.9 
(1.79–1.95) 
 
3 
(2.86–3.17) 
4.4 
(4.17–4.72) 
Associations of 
maternal obesity with 
blood pressure and the 
risks of gestational 
hypertensive disorders. 
The generation R study 
 
1.82 
(1.16–2.83) 
 
2.49 
(1.29–4.78) 
3.40 
(1.39–8.28) 
Determinants of 
preeclampsia: a case 
control study in a district 
hospital in south India. 
 
. 7.56 
(1.32-43.37) 
. 
Prepregnancy body 
mass index, gestational 
weight gain, and risk of 
hypertensive pregnancy 
among Latina women. 
 
. 2.7 
(1.2-5.8) 
 
 
 
. 
Prepregnancy weight 
status and the risk of 
adverse pregnancy 
outcomes.  
 
1.55 
(1.30-1.86) 
 
3.10 
(2.54- 3.78) 
 
. 
Prepregnancy body 
mass index and 
adverse pregnancy 
outcomes. 
  
1.457 
(0.576–3.689) 
5.68 
(2.524-12.815) 
. 
Prepregnancy body 
mass index and the 
occurrence of severe 
hypertensive disorders 
Whites vs Blacks 
1.7 
(1.1–2.5) 
 
3.4 
(2.1–5.6) 
 
7.6 
(4.2–13.7) 
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of pregnancy.   
2.1 
(1.4–3.2) 
 
3.2 
(2.1–5.0) 
 
 
5.3 
(2.9–9.7) 
Effect of prepregnancy 
body mass index 
categories on 
obstetrical and neonatal 
outcomes.  
 
2.28 
(1.88–2.77) 
 
4.65 
(3.71–5.83) 
 
 
6.26 
(3.48-11.26) 
The risk of 
preeclampsia rises with 
increasing 
prepregnancy body 
mass index.  
26 
2.1 
(1.4, 3.4) 
28 
2.6  
(1.5, 4.5) 
 
30 
2.9 
(1.6, 5.3) 
35 
2.8 
(1.4, 5.7) 
 
40 
2.3 
(0.80, 6.4) 
Adult weight change, 
weight cycling, and 
prepregnancy obesity in 
relation to risk of 
preeclampsia.  
 
2.1 
(0.6-7.0) 
 
0.6 
(0.1-4.6) 
. 
Interpretation of findings 
Prepregnancy BMI was consistently shown to be associated with 
preeclampsia. ORs for this association ranged from 1.7 – 7 in different BMI 
categories. The risk of preeclampsia increased with higher BMI categories. This 
finding was consistent in all studies reviewed. Bodnar et al.(36) reported that 
compared to women with BMI of 21, the risk of preeclampsia was double for BMI 
of 26 and almost tripled for women with BMI 30. Also this study found that the 
risk of preeclampsia rises even within each traditional BMI category, e.g., within 
obese BMI category (30-35), women with BMI 35 have higher risk of 
preeclampsia compared to women with BMI 30 or 31. In addition, women at the 
age of 18 and classified as overweight had 2.1 fold increased risk of 
preeclampsia compared with women of same age and normal BMI. Every 1kg/m2 
in prepregnancy BMI resulted in an 8% increased risk of preeclampsia. A history 
of intentional weight cycling (defined as intentional weight loss and unintentional 
weight gain) was associated with 1.5 increase in risk of preeclampsia.(37) 
Apart from preeclampsia, some of the studies additionally reported 
increased risk for other maternal and newborn adverse outcomes for higher BMI 
categories. Obesity was shown to be associated with increased risk of cesarean 
section,(38)(39) gestational hypertension and preterm birth.(40) Two of the studies 
(41)(42) reported increased risk of fetal macrosomia (≥ 4000g) in overweight (OR= 
1.96), and obese (OR=2.58) women. 
The importance of socioeconomic status and health disparities were 
highlighted in at least two of the studies that studied the association between BMI 
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and maternal adverse outcomes including preeclampsia in minority populations 
such as blacks and Latinas. One of the studies(43) found preeclampsia to be more 
common among Blacks (4.5%) than whites (2.7%). Adjusted ORs ranged from 
0.7-4.9 for mild preeclampsia and 0.8- 7.6 for severe preeclampsia among 
Blacks compared to Whites with ORs of 1-4.2 for mild preeclampsia and 1.4-5.3 
for severe preeclampsia for different age groups (17-35). Black women were 
found to be of low socioeconomic status, be 21 or younger, and obese compared 
to white women. In this study race/ethnicity was found to play a role in the 
relationship between BMI and preeclampsia as an effect modifier. Another 
study(44) was conducted to understand this relationship in Latina women. The 
results of this study reported that Latina women with prepregnancy obesity have 
3-fold risks for hypertensive disorders and preeclampsia compared to normal 
weight women.  
Limitations of the review/studies 
The main methodological limitations for reviewed studies were self-
reported prepregnancy weight, small sample size and unmeasured confounding 
variables, which might have biased the results. In order to obtain women’s 
prepregnancy BMI, information on women’s weight prior to pregnancy was 
obtained through self-report using questionnaires and interviews. Only one of the 
studies reported verification of this information with medical records. This kind of 
information collection is always subject to recall bias and might cause 
misclassification of subjects into inaccurate categories.(45) In addition, information 
about socio-demographic and behavioral variables such as diet, physical activity 
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before pregnancy, family history of preeclampsia, smoking etc. before pregnancy 
was also collected through self-reports for all the studies. In addition, none of the 
studies adjusted for possible confounders such as prepregnancy dietary intake, 
access to health services, maternal and paternal genetic factors. Small sample 
size(46) made it challenging in some of these studies to calculate the risk of 
preeclampsia in all BMI categories.(47) 
Other limitations included: inappropriate measurement of blood pressure 
in obese women and lacking data on other surrogates of prepregnancy adiposity 
such as prepregnancy waist circumference or skinfold measurements, which 
might have served as more robust measures of adiposity and its association with 
hypertensive disorders of pregnancy. Some studies reported (48) residual 
confounding; self reported data, small sample size (49) and lack of generalizability 
of the results (50)(51) as limitations for the study. Due to small sample size in these 
studies and heterogeneity of preeclampsia as a disease condition, study 
participants were too homogenous (for instance studying preeclampsia only in 
diabetic patients or clients of a specific health facility) thus the results of these 
studies cannot be generalized to other populations of women with possible risk of 
preeclampsia.(52)(53)(54) 
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Policy implications/recommendations and significance for Maternal and 
Child Health 
 Overweight and obese BMI is associated with preeclampsia as a dose-
response association and thus may be a target to reduce the incidence of 
preeclampsia.(34)  
 Life style intervention programs may be key to overcoming the challenge 
of obesity and weight gain during pregnancy.(30) This can be accomplished 
through raising awareness of women about weight gain, healthy eating 
during pregnancy, promoting overall healthy lifestyle habits and organizing 
preconception counseling for reproductive age women. Such initiatives 
may not only lower the risk of preeclampsia, but also prevent other 
adverse health conditions and chronic diseases such as diabetes and 
hypertension.  
 Specific studies should be designed to evaluate interventions that focus 
on women who enter pregnancy with high BMI. These women can be 
recognized as high risk and targeted for interventions, such as lifestyle 
interventions (others may include medication use such as low dose aspirin 
to prevention preeclampsia). 
 Preeclampsia is a heterogeneous condition with possibly sub-
classifications of the disease such as early onset and late onset having 
different etiologies. Future research should focus on larger sample sizes 
studying these sub-classifications of the disease, in relationship to 
prepregnancy BMI.(55)   
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 Considering the racial/ethnic disparities in the incidence of preeclampsia 
in one of the studies, more studies can be conducted to understand the 
racial/ethnic interactions with prepregnancy adiposity and elucidate 
mechanisms causing these differences.(32)  
 Public health campaigns are recommended to target young adults 
(specifically women of reproductive age) who might have risk factors for 
developing preeclampsia. These campaigns can promote behavior and 
dietary changes to improve reproductive health outcomes and long-term 
health condition.  
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Conclusions 
Maternal body fat was assumed to be associated with preeclampsia as 
long ago as 1810.(56) Obesity is shown to be strongly associated with increased 
mortality and morbidity during labor and delivery as well as puerperium. Obese 
women need more intensive care during labor and are likely to end up having C-
sections and as a result are at higher risk for surgical complications such as 
bleeding, thrombophlebitis, infections, etc.  
The exact mechanism of relationship between BMI and preeclampsia is 
yet not clearly understood. There is possibly more than one mechanism 
associated with development of preeclampsia.(57) It is assumed that reduced 
placental perfusion as a result of abnormal placentation is the main feature. 
However, evidence shows that not all women who have reduced placental 
perfusion end up developing preeclampsia. This finding has led scientists to 
assume that for development of preeclampsia apart from placental hypo-
perfusion, some maternal genetic, environmental and behavior characteristics 
need to be present. In such women, a predisposing factor such as obesity can 
trigger endothelial dysfunction, oxidative stress, and initiation of coagulation 
cascade and finally cause preeclampsia.(58) 
In a literature review of 10 epidemiologic studies higher BMI before 
pregnancy was consistently shown to be associated with increased risk of 
preeclampsia. ORs ranged from 1.2-2.28 for overweight, from 2.49-7.56 for 
obese and from 3.4-7.6 for severely obese individuals. One of the studies (57) 
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reported that a 1.6kg/m2 lowering of prepregnancy BMI from 29 to 27.4, the 
equivalent of 4.5kg in women whose heights are 65 inches could reduce the risk 
of preeclampsia by 50%. These studies showed that obese women have not only 
higher risk for preeclampsia, but also increased risk for other adverse outcomes 
such as gestational hypertension, cesarean section and diabetes. In addition, 
prepregnancy BMI was found to be associated with adverse neonatal outcomes 
such as macrosomia and preterm birth. Furthermore, one of the studies reported 
higher risk of preeclampsia among black women who have higher BMI compared 
to white women.  
Obesity is an important health problem in the United States ranked as the 
second leading cause of death.(59) Obesity is also associated with various 
morbidity and chronic health conditions such as hypertension, cardiovascular 
diseases and diabetes. Almost 6-7% of national health expenditures in the US 
are spent for obesity. Maternal obesity is associated with life threatening 
conditions and morbidities for both mother and the newborn. (58) With increased 
prevalence of obesity in the world in recent years,(59) more research and 
interventions need to be geared towards overcoming the problem of obesity and 
its associated adverse outcomes for women of reproductive age.  
In the context of Maternal and Child Health Pyramid, different 
interventions at different levels may help overcome the challenge of obesity in 
women of reproductive age. At the level of population-based services, life style 
modification interventions with an emphasis on public education and 
preconception counseling may lower the risk of preeclampsia in women of 
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reproductive age. Public health programs can promote healthy eating habits and 
losing weight. These interventions can target women of reproductive age in 
general and women with higher BMI in particular with appropriate programs. At 
the level of enabling services, women with higher BMI entering pregnancy can be 
identified and targeted for health education and family support services. At the 
level of infrastructure building services, more research with larger sample sizes 
might provide scientifically reliable conclusions for subcategories of this 
heterogeneous disease. Further research can follow to evaluate the efficacy, 
effectiveness and longer-term impact of interventions and programs 
implemented.  
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